Clinical trial
Immunotherapy by Nivolumab for HIV+ Patients
NCT03304093
Study timeline
Study start (actual)2017-10-19Date precision: day
Registry last updated2023-05-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancer Metastaticunresolved
Non Small Cell Lung Cancer Stage IIIBunresolved
HIV/AIDSunresolved
Interventions
Nivolumab InjectionDRUG · verified · RxNorm: nivolumab Injection
Sponsors & collaborators
ANRS, Emerging Infectious Diseasescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03304093 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.